Knowledge, Attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
NCT ID: NCT06743880
Last Updated: 2024-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
323 participants
OBSERVATIONAL
2025-01-01
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* HPV infections can lead to the development of precancerous lesions on the cervix, which if left untreated, can progress to invasive cervical cancer over time.
* Cervical cancer is the second most common cancer among women in Egypt, after breast cancer.
* According to the latest available data, the age-standardized incidence rate of cervical cancer in Egypt is approximately 6.3 per 100,000 women.
* However, the actual burden of cervical cancer in Egypt is likely underestimated, as many cases may go undetected or unreported, especially in rural and underserved areas.
The main objectives of this KAP study are:
1. To assess the level of knowledge about HPV and HPV vaccination among the target population.
2. To investigate the attitudes and perceptions towards HPV vaccination.
3. To identify the current practices and uptake of HPV vaccination.
4. To explore the factors influencing the knowledge, attitudes, and practices related to HPV vaccination.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Risk Factors and Epidemiology:
* The primary risk factor for cervical cancer in Egypt is persistent infection with high-risk strains of the human papillomavirus (HPV), particularly HPV 16 and 18.
* Other risk factors include early age of first sexual intercourse, multiple sexual partners, high parity, smoking, and lack of regular cervical cancer screening.
* Socioeconomic factors, such as low education levels and limited access to healthcare services, also contribute to the cervical cancer burden in Egypt.
* Cervical cancer disproportionately affects women in rural and disadvantaged areas, where screening and preventive services are less accessible.
Screening and Prevention Efforts:
* Cervical cancer screening through Pap smears or HPV testing is the primary method for early detection and prevention of the disease.
* However, cervical cancer screening coverage in Egypt remains low, with only around 10-20% of eligible women being regularly screened.
* The Egyptian Ministry of Health and Population has implemented various initiatives to improve cervical cancer screening and awareness, but more efforts are needed to reach underserved populations.
* The introduction and widespread uptake of the HPV vaccine could significantly reduce the burden of cervical cancer in Egypt, but vaccine coverage remains suboptimal.
* Cervical cancer is a significant public health concern, as it is the fourth most common cancer in women worldwide, with a high mortality rate, especially in developing countries.
* Early detection through regular cervical cancer screening (e.g., Pap smears) and treatment of precancerous lesions can effectively prevent the development of cervical cancer.
Role of the HPV Vaccine:
* The HPV vaccine is a highly effective way to prevent cervical cancer and other HPV-related diseases, such as anal, penile, and oropharyngeal cancers.
* The vaccine targets the HPV strains (primarily HPV 16 and 18) that are responsible for approximately 70% of cervical cancer cases globally.
* The HPV vaccine is recommended for both girls and boys, typically starting at 11-12 years of age, as it is most effective when administered before the onset of sexual activity and potential HPV exposure.
* Widespread HPV vaccination, coupled with regular cervical cancer screening, has the potential to significantly reduce the burden of cervical cancer worldwide.
Importance of a KAP Questionnaire in Egypt:
* In Egypt, cervical cancer is the second most common cancer among women, and HPV infection is a major risk factor.
* However, HPV vaccination rates in Egypt remain relatively low, indicating a need to better understand the factors that influence vaccination uptake in the country.
* A KAP questionnaire can provide valuable insights into:
* The level of awareness and knowledge about cervical cancer and the HPV vaccine among the Egyptian population.
* Attitudes, beliefs, and misconceptions that may be hindering or promoting HPV vaccination.
* Current vaccination practices and barriers to accessing the vaccine.
* This information can then be used to develop targeted educational campaigns, address misconceptions, and implement strategies to improve HPV vaccination coverage in Egypt.
* By understanding the KAP of HPV vaccination, policymakers and healthcare providers can work to increase cervical cancer prevention efforts and improve the overall public health outcomes in the country.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
health care provider group
\- Healthcare providers at the Gynecologic Oncology Unit have direct interactions with patients and can significantly influence their knowledge, attitudes, and decision-making regarding HPV vaccination.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligibility criteria:
* Age: 9-79 years old
* patients and their relatives
* Attending the Obstetrics and Gynecology, or Family Medicine clinics at Assiut University Hospital
* Recruitment strategy:
* Using a systematic random sampling method, every nth patient (based on the average patient load) will be approached and invited to participate in the study.
* The target sample size for patients is a minimum of 384 participants.
2\. Healthcare providers:
* Eligibility criteria:
* Physicians, nurses, and other healthcare workers employed in the Obstetrics and Gynecology, and Family Medicine departments at Assiut University Hospital.
Exclusion Criteria
* Exclude participants who have already received the complete HPV vaccination series, as their knowledge, attitudes, and practices may differ from those who are unvaccinated.
* The study aims to understand the KAP of the unvaccinated population, which is the primary target group for intervention.
2-Severe Cognitive or Mental Impairment:
* Exclude participants who have severe cognitive or mental impairments that may prevent them from understanding and responding to the questionnaire accurately.
* This could include individuals with advanced dementia, severe intellectual disabilities, or acute psychiatric conditions.
3-. Inability to Provide Informed Consent:
* Exclude participants who are unable to provide informed consent due to language barriers, literacy issues, or other factors that may compromise their ability to understand the study and its implications 4- Severe Illness or Hospitalization:
* Exclude participants who are currently hospitalized or experiencing severe illness, as their focus may be on their immediate health concerns rather than the KAP questionnaire.
9 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdelaaziz Mohamed Fathi
resident doctor at Assiut University hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Abdelaaziz Mohamed Fathi, resident doctor
Role: CONTACT
Phone: +201005610660
Email: [email protected]
References
Explore related publications, articles, or registry entries linked to this study.
Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007 Aug-Sep;45(2-3):107-14. doi: 10.1016/j.ypmed.2007.05.013. Epub 2007 Jun 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAP ON HPV vaccination
Identifier Type: -
Identifier Source: org_study_id